In this study, we demonstrated that metronomic chemoendocrine therapy increased the expression of autophagy-related markers, beclin 1 and LC3, and the expression of apoptosis-related markers, TUNEL and M30, in HR-positive breast cancer tissues. The gene discussed is BECN1; the disease is breast carcinoma.